Immunohistochemistry analysis demonstrated a decline in RHBDD2 expression in the miR-4739 mimics group, while an increase was observed in the group where miR-4739 mimics were combined with RHBDD2 in xenograft tumor tissues (Fig. 6D). The gene discussed is RHBDD2; the disease is neoplasm.